1410 related articles for article (PubMed ID: 30152151)
1. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
2. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
3. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
4. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus.
Lilleby V; Flatø B; Førre O
Clin Exp Rheumatol; 2005; 23(2):261-9. PubMed ID: 15895902
[TBL] [Abstract][Full Text] [Related]
5. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
[TBL] [Abstract][Full Text] [Related]
6. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
[TBL] [Abstract][Full Text] [Related]
8. Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients.
Moorthy LN; Baldino ME; Kurra V; Puwar D; Llanos A; Peterson MG; Hassett AL; Lehman TJ;
Lupus; 2017 Mar; 26(3):255-265. PubMed ID: 27496901
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus.
Mok CC; Ho LY; Tse SM; Chan KL
Ann Rheum Dis; 2017 Aug; 76(8):1420-1425. PubMed ID: 28432050
[TBL] [Abstract][Full Text] [Related]
11. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
[TBL] [Abstract][Full Text] [Related]
12. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
14. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
[TBL] [Abstract][Full Text] [Related]
15. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
[TBL] [Abstract][Full Text] [Related]
16. Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
Elera-Fitzcarrald C; Reátegui-Sokolova C; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Zeña-Huancas PA; Pastor-Asurza CA; Perich-Campos RA; Rodríguez-Bellido ZJ; Alarcón GS; Ugarte-Gil MF
Lupus; 2020 Oct; 29(12):1644-1649. PubMed ID: 32741305
[TBL] [Abstract][Full Text] [Related]
17. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.
Hill DD; Eudy AM; Egger PJ; Fu Q; Petri MA
Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33832976
[TBL] [Abstract][Full Text] [Related]
18. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.
Mak A; Mok CC; Chu WP; To CH; Wong SN; Au TC
Lupus; 2007; 16(1):28-34. PubMed ID: 17283582
[TBL] [Abstract][Full Text] [Related]
19. Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
Parodis I; Johansson P; Gomez A; Soukka S; Emamikia S; Chatzidionysiou K
Rheumatology (Oxford); 2019 Dec; 58(12):2170-2176. PubMed ID: 31157891
[TBL] [Abstract][Full Text] [Related]
20. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
